We are live on ! Find out more
Federated Hermes

Federated Hermes Portfolio holdings

AUM $69.6B
1-Year Est. Return 42.52%
This Fund
S&P 500
This Quarter Est. Return
+3.9%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$45.7B
AUM Growth
+$116M
Cap. Flow
-$39.4M
Cap. Flow %
-0.09%
Top 10 Hldgs %
13.84%
Holding
2,228
New
172
Increased
849
Reduced
944
Closed
160

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$176M
2
JNJ icon
Johnson & Johnson
JNJ
+$157M
3
ABBV icon
AbbVie
ABBV
+$128M
4
AMGN icon
Amgen
AMGN
+$115M
5
GEV icon
GE Vernova
GEV
+$109M

Top Sells

Rank Stock Value
1
ETR icon
Entergy
ETR
+$152M
2
D icon
Dominion Energy
D
+$132M
3
APP icon
Applovin
APP
+$114M
4
MS icon
Morgan Stanley
MS
+$108M
5
BCE icon
BCE
BCE
+$99.5M

Sector Composition

Rank Sector Weight
1 Technology 20.58%
2 Healthcare 15.8%
3 Financials 14.36%
4 Industrials 10.83%
5 Consumer Discretionary 9.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
URBN icon
2051
Urban Outfitters
URBN
$6.6B
$220 ﹤0.01%
4
LZB icon
2052
La-Z-Boy
LZB
$1.24B
$174 ﹤0.01%
4
+1
+33% +$42
REX icon
2053
REX American Resources
REX
$1.39B
$167 ﹤0.01%
8
PRDO icon
2054
Perdoceo Education
PRDO
$2.07B
$106 ﹤0.01%
4
-42
-91% -$1.03K
PRM icon
2055
Perimeter Solutions
PRM
$5.11B
$51 ﹤0.01%
4
+1
+33% +$13
OCUL icon
2056
Ocular Therapeutix
OCUL
$2.35B
$34 ﹤0.01%
4
+1
+33% +$10
COGT icon
2057
Cogent Biosciences
COGT
$5.8B
$31 ﹤0.01%
4
+1
+33% +$10
GRPN icon
2058
Groupon
GRPN
$777M
$24 ﹤0.01%
2
MQ icon
2059
Marqeta
MQ
$1.73B
$19 ﹤0.01%
1
PRME icon
2060
Prime Medicine
PRME
$577M
$18 ﹤0.01%
6
+2
+50% +$7
SB icon
2061
Safe Bulkers
SB
$850M
$14 ﹤0.01%
4
+1
+33% +$4
SGHC icon
2062
SGHC Ltd
SGHC
$7.06B
$12 ﹤0.01%
2
+1
+100% +$5
EGY icon
2063
Vaalco Energy
EGY
$660M
$9 ﹤0.01%
2
+1
+100% +$5
SANA icon
2064
Sana Biotechnology
SANA
$958M
$8 ﹤0.01%
5
+2
+67% +$6
LAB icon
2065
Standard BioTools
LAB
$273M
$5 ﹤0.01%
3
+1
+50% +$2
SCLX icon
2066
Scilex Holding
SCLX
$35.9M
0
ABSI icon
2067
Absci
ABSI
$1.39B
-3
Closed -$11
ABUS icon
2068
Arbutus Biopharma
ABUS
$1.02B
-3
Closed -$12
ACTG icon
2069
Acacia Research
ACTG
$437M
-6
Closed -$28
AEE icon
2070
Ameren
AEE
$28.8B
-1,502
Closed -$131K
OSG
2071
Octave Specialty Group
OSG
$225M
-2,503
Closed -$28.1K
AMC icon
2072
AMC Entertainment Holdings
AMC
$2.23B
-3
Closed -$14
ANIK icon
2073
Anika Therapeutics
ANIK
$284M
-114
Closed -$2.82K
ANIP icon
2074
ANI Pharmaceuticals
ANIP
$1.62B
-118
Closed -$7.04K
AOSL icon
2075
Alpha and Omega Semiconductor
AOSL
$733M
-893
Closed -$33.1K

Similar funds

Federated Hermes's Q4 2024 Portfolio in Review

As of Q4 2024, Federated Hermes held 2,228 positions worth $45.7B, up 0.25% from $45.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Federated Hermes's Q4 2024 filing shows 172 new, 849 increased, 944 reduced and 160 closed positions. Its largest new stake was StandardAero Inc: 2,510,500 shares worth $62.2M. The largest sale was Entergy, an estimated $152M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

  • Federated Hermes's largest Q4 2024 buy was StandardAero Inc: 2,510,500 shares worth $62.2M.
  • Federated Hermes added most to ExxonMobil in Q4 2024, an estimated $176M increase.
  • Federated Hermes's biggest Q4 2024 reduction was Entergy, cutting an estimated $152M.
  • Federated Hermes fully exited Huazhu Hotels Group in Q4 2024, selling an estimated $75.1M.
  • Federated Hermes's ten largest holdings make up 14% of its $45.7B portfolio in Q4 2024.
  • Federated Hermes opened 172 new positions and closed 160 in Q4 2024.
  • Federated Hermes's portfolio value rose 0.25% quarter-over-quarter to $45.7B.

Based on Federated Hermes's 13F filing for Q4 2024, filed 13 Feb 2025.